Navigating Keratoconus: A Comprehensive Guide for Optometrists
In the realm of optometry, keratoconus is a condition that demands our utmost attention and expertise. As optometrists, we play a pivotal role in identifying, managing, and treating this progressive eye disease. This article serves as a comprehensive guide, drawing from clinical trials, registry data, and consensus guidance, to equip us with the knowledge and tools necessary to provide optimal care for our patients with keratoconus.
Early Detection: Unraveling the Clues
The journey begins with a keen eye for early signs and symptoms. Patients with keratoconus often present with blurred or distorted vision, increased light sensitivity, and frequent refractive changes, particularly progressive astigmatism. It's crucial to recognize common risk factors such as eye rubbing, atopy, family history, and conditions like trisomy 21 (Down's syndrome).
During the clinical examination, we may encounter various signs. Retinoscopy might reveal an oil-drop sign or scissoring. Slit lamp examination may disclose Vogt's striae, apical thinning, scarring, and Fleischer rings. Munson's sign, characterized by bulging of the lower lid, is indicative of advanced disease. Atopic keratoconjunctivitis, marked by a papillary conjunctival reaction with hyperaemia, can also be present.
Corneal curvature measurements, such as keratometry, play a vital role in diagnosis. A steep cornea with a reading exceeding 50D is a strong indicator of keratoconus. However, it's essential to note that readings may appear normal early if the cone is not central. Modern imaging techniques, including Pentacam, Galilei, topographers, and anterior segment OCT, offer inbuilt algorithms to confirm the diagnosis.
Subclinical Keratoconus: A Grey Area
In cases where the diagnosis is uncertain, we must consider the possibility of subclinical keratoconus, forme fruste keratoconus, or keratoconus suspects. This classification is crucial for managing patients effectively.
Management Strategies: Progression, Visual Rehabilitation, and Comorbidities
The management of keratoconus involves a multifaceted approach. We must assess and treat progression, ensure visual rehabilitation, and address any comorbidities. The impact on mental health should not be overlooked, and support from the patient's general practitioner may be necessary.
Progression management is a critical aspect. Steeper Kmax and younger age are significant predictors of progression. Patients with a Kmax greater than 55D and those under 17 years of age require closer monitoring and a lower threshold for corneal cross-linking (CXL).
CXL, the gold standard treatment, has proven efficacy and safety in preventing progression and improving vision. It is recommended soon after diagnosis, with epithelium-off techniques being preferred. Early referral is crucial, especially for younger patients, those with a family history, and those demonstrating progression.
Visual rehabilitation is tailored to the patient's needs. The goal is to restore functional vision rather than necessarily achieving 6/6 vision. Non-surgical management options include unaided vision, spectacles, and contact lenses. Hard contact lenses are essential for correcting irregular astigmatism, while surgical interventions like corneal grafting, deep anterior lamellar keratoplasty (DALK), and laser procedures offer further treatment avenues.
Long-Term Management and Benchmarking
Long-term follow-up is imperative for patients with keratoconus. The frequency of visits depends on their risk of progression and treatment needs. In children and adolescents, close monitoring is required due to rapid progression. As patients approach 30 years of age, follow-up intervals can be reduced to annually.
The Save Sight Keratoconus Registry is a valuable tool for tracking patient outcomes, benchmarking practice against national and international standards, and sharing data between ophthalmologists and optometrists. It allows us to audit various treatments, including cross-linking, corneal grafting, laser, and ring segments. The optometry module enables optometrists to track refractive measures, and patient-reported outcomes can be captured using the Keratoconus Outcomes Research Questionnaire (KORQ).
In conclusion, managing keratoconus is a rewarding endeavor, offering us the opportunity to prevent progression and enhance our patients' quality of life. By embracing the latest evidence-based practices and utilizing resources like the Save Sight Keratoconus Registry, we can provide exceptional care and make a tangible difference in the lives of those affected by this challenging condition.
